APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pathological Examination

A pathomorphological method used to examine pathological changes in organs, tissues or cells. In order to explore the disease process of organs, tissues or cells, some pathomorphological examination method can be used to check the pathological changes, explore the causes, pathogenesis, occurrence and development process of lesions, and finally make pathological diagnosis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A pathomorphological method used to examine pathological changes in organs, tissues or cells. In order to explore the disease process of organs, tissues or cells, some pathomorphological examination method can be used to check the pathological changes, explore the causes, pathogenesis, occurrence and development process of lesions, and finally make pathological diagnosis.

Selected research

Market Analysis & Forecast

Global Pathological Examination Market Analysis and Forecast 2026-2032

Report ID 173895090228 December 2025191 pages

Choose your research edition.

Industry ResearchPathological Examination Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Pathological Examination Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Pathological Examination Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pathological Examination Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Pathological Examination Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

A pathomorphological method used to examine pathological changes in organs, tissues or cells. In order to explore the disease process of organs, tissues or cells, some pathomorphological examination method can be used to check the pathological changes, explore the causes, pathogenesis, occurrence and development process of lesions, and finally make pathological diagnosis.

From perspective of type, pathological examination can be split into histopathology, cell pathology, immunohistochemical pathology and molecular pathology. In 2019, cell pathology took up for about 48% market share, which made it the largest segment of global pathological examination.

North America is the largest consumption region of pathological examination, with a consumption market share nearly 37% in 2019. The second place is Asia-Pacific; following North America with the consumption market share over 31% in 2020.

Read the full market overview

Key players of global pathological examination market are Quest Diagnostics, Sonic Healthcare, Lab Corp, Unilabs, SYNLAB International. The top 5 players totally took up a market share of about 18% in 2019. Quest Diagnostics is in the first place, which accounted for above 5% of global market.

Report Includes

This report presents an overview of global market for Pathological Examination, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pathological Examination, also provides the revenue of main regions and countries. Of the upcoming market potential for Pathological Examination, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pathological Examination revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pathological Examination market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pathological Examination revenue, projected growth trends, production technology, application and end-user industry.

Pathological Examination Segment by Company

Quest Diagnostics

Sonic Healthcare

Lab Corp

Unilabs

SYNLAB International

BML

Pathologists Diagnostic

StageBio

KingMed Diagnostics Group

Dian Diagnostics Group

Adicon Clinical Laboratories Inc.

Huayin Health

Pathological Examination Segment by Type

Histopathology

Cytopathology

Immunohistochemical Pathology

Molecular Pathology

Pathological Examination Segment by Application

Hospital

Medical Laboratory

Pathological Examination Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pathological Examination market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pathological Examination and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pathological Examination.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pathological Examination in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pathological Examination company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pathological Examination revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pathological Examination Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Histopathology Major Player Table 3. Cytopathology Major Player Table 4. Immunohistochemical Pathology Major Player Table 5. Molecular Pathology Major Player Table 6. Global Pathological Examination Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Player Table 8. Medical Laboratory Major Player Table 9. Pathological Examination Industry Trends Table 10. Pathological Examination Industry Drivers Table 11. Pathological Examination Industry Opportunities and Challenges Table 12. Pathological Examination Industry Restraints Table 13. Global Pathological Examination Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Pathological Examination Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Pathological Examination Market Share by Region (2021-2026) Table 16. Global Pathological Examination Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Pathological Examination Market Share by Region (2027-2032) Table 18. Global Pathological Examination Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Pathological Examination Revenue Market Share by Players (2021-2026) Table 20. Global Pathological Examination Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Pathological Examination Key Players Headquarters & Area Served Table 22. Global Pathological Examination Players, Product Type & Application Table 23. Global Pathological Examination Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Pathological Examination by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Pathological Examination Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pathological Examination Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Pathological Examination Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Pathological Examination Revenue Market Share by Type (2021-2026) Table 30. Global Pathological Examination Revenue Market Share by Type (2027-2032) Table 31. Global Pathological Examination Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pathological Examination Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Pathological Examination Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Pathological Examination Revenue Market Share by Application (2021-2026) Table 35. Global Pathological Examination Revenue Market Share by Application (2027-2032) Table 36. Quest Diagnostics Company Information Table 37. Quest Diagnostics Business Overview Table 38. Quest Diagnostics Pathological Examination Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Quest Diagnostics Pathological Examination Product Portfolio Table 40. Quest Diagnostics Recent Development Table 41. Sonic Healthcare Company Information Table 42. Sonic Healthcare Business Overview Table 43. Sonic Healthcare Pathological Examination Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Sonic Healthcare Pathological Examination Product Portfolio Table 45. Sonic Healthcare Recent Development Table 46. Lab Corp Company Information Table 47. Lab Corp Business Overview Table 48. Lab Corp Pathological Examination Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Lab Corp Pathological Examination Product Portfolio Table 50. Lab Corp Recent Development Table 51. Unilabs Company Information Table 52. Unilabs Business Overview Table 53. Unilabs Pathological Examination Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Unilabs Pathological Examination Product Portfolio Table 55. Unilabs Recent Development Table 56. SYNLAB International Company Information Table 57. SYNLAB International Business Overview Table 58. SYNLAB International Pathological Examination Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. SYNLAB International Pathological Examination Product Portfolio Table 60. SYNLAB International Recent Development Table 61. BML Company Information Table 62. BML Business Overview Table 63. BML Pathological Examination Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. BML Pathological Examination Product Portfolio Table 65. BML Recent Development Table 66. Pathologists Diagnostic Company Information Table 67. Pathologists Diagnostic Business Overview Table 68. Pathologists Diagnostic Pathological Examination Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Pathologists Diagnostic Pathological Examination Product Portfolio Table 70. Pathologists Diagnostic Recent Development Table 71. StageBio Company Information Table 72. StageBio Business Overview Table 73. StageBio Pathological Examination Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. StageBio Pathological Examination Product Portfolio Table 75. StageBio Recent Development Table 76. KingMed Diagnostics Group Company Information Table 77. KingMed Diagnostics Group Business Overview Table 78. KingMed Diagnostics Group Pathological Examination Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. KingMed Diagnostics Group Pathological Examination Product Portfolio Table 80. KingMed Diagnostics Group Recent Development Table 81. Dian Diagnostics Group Company Information Table 82. Dian Diagnostics Group Business Overview Table 83. Dian Diagnostics Group Pathological Examination Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Dian Diagnostics Group Pathological Examination Product Portfolio Table 85. Dian Diagnostics Group Recent Development Table 86. Adicon Clinical Laboratories Inc. Company Information Table 87. Adicon Clinical Laboratories Inc. Business Overview Table 88. Adicon Clinical Laboratories Inc. Pathological Examination Sales (), Revenue (US$ Million), Price (USD million) and Gross Margin (2021-2026) Table 89. Adicon Clinical Laboratories Inc. Pathological Examination Product Portfolio Table 90. Adicon Clinical Laboratories Inc. Recent Development Table 91. Huayin Health Company Information Table 92. Huayin Health Business Overview Table 93. Huayin Health Pathological Examination Sales (), Revenue (US$ Million), Price (USD million) and Gross Margin (2021-2026) Table 94. Huayin Health Pathological Examination Product Portfolio Table 95. Huayin Health Recent Development Table 96. North America Pathological Examination Revenue by Type (2021-2026) & (US$ Million) Table 97. North America Pathological Examination Revenue by Type (2027-2032) & (US$ Million) Table 98. North America Pathological Examination Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Pathological Examination Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Pathological Examination Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Pathological Examination Revenue by Country (2021-2026) & (US$ Million) Table 102. North America Pathological Examination Revenue by Country (US$ Million) & (2027-2032) Table 103. Europe Pathological Examination Revenue by Type (2021-2026) & (US$ Million) Table 104. Europe Pathological Examination Revenue by Type (2027-2032) & (US$ Million) Table 105. Europe Pathological Examination Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe Pathological Examination Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe Pathological Examination Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Pathological Examination Revenue by Country (2021-2026) & (US$ Million) Table 109. Europe Pathological Examination Revenue by Country (US$ Million) & (2027-2032) Table 110. China Pathological Examination Revenue by Type (2021-2026) & (US$ Million) Table 111. China Pathological Examination Revenue by Type (2027-2032) & (US$ Million) Table 112. China Pathological Examination Revenue by Application (2021-2026) & (US$ Million) Table 113. China Pathological Examination Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia Pathological Examination Revenue by Type (2021-2026) & (US$ Million) Table 115. Asia Pathological Examination Revenue by Type (2027-2032) & (US$ Million) Table 116. Asia Pathological Examination Revenue by Application (2021-2026) & (US$ Million) Table 117. Asia Pathological Examination Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Pathological Examination Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Asia Pathological Examination Revenue by Region (US$ Million) & (2021-2026) Table 120. Asia Pathological Examination Revenue by Region (US$ Million) & (2027-2032) Table 121. SAMEA Pathological Examination Revenue by Type (2021-2026) & (US$ Million) Table 122. SAMEA Pathological Examination Revenue by Type (2027-2032) & (US$ Million) Table 123. SAMEA Pathological Examination Revenue by Application (2021-2026) & (US$ Million) Table 124. SAMEA Pathological Examination Revenue by Application (2027-2032) & (US$ Million) Table 125. SAMEA Pathological Examination Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. SAMEA Pathological Examination Revenue by Country (2021-2026) & (US$ Million) Table 127. SAMEA Pathological Examination Revenue by Country (US$ Million) & (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Pathological Examination Image Figure 2. Global Pathological Examination Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pathological Examination Market Size Share 2021 VS 2025 VS 2032 Figure 4. Histopathology Image Figure 5. Cytopathology Image Figure 6. Immunohistochemical Pathology Image Figure 7. Molecular Pathology Image Figure 8. Global Pathological Examination Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Pathological Examination Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Medical Laboratory Image Figure 12. Global Pathological Examination Market Size (US$ Million) & (2021-2032) Figure 13. Global Pathological Examination Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Pathological Examination Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Pathological Examination Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Pathological Examination Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pathological Examination Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Pathological Examination Revenue Market Share by Type (2021-2032) Figure 20. Global Pathological Examination Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Pathological Examination Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Pathological Examination Revenue Market Share by Application (2021-2032) Figure 23. North America Pathological Examination Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Pathological Examination Revenue Share by Type (2021-2032) Figure 25. North America Pathological Examination Revenue Share by Application (2021-2032) Figure 26. North America Pathological Examination Revenue Share by Country (2021-2032) Figure 27. United States Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Pathological Examination Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Pathological Examination Revenue Share by Type (2021-2032) Figure 32. Europe Pathological Examination Revenue Share by Application (2021-2032) Figure 33. Europe Pathological Examination Revenue Share by Country (2021-2032) Figure 34. Germany Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Pathological Examination Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Pathological Examination Revenue Share by Type (2021-2032) Figure 44. China Pathological Examination Revenue Share by Application (2021-2032) Figure 45. Asia Pathological Examination Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Pathological Examination Revenue Share by Type (2021-2032) Figure 47. Asia Pathological Examination Revenue Share by Application (2021-2032) Figure 48. Asia Pathological Examination Revenue Share by Region (2021-2032) Figure 49. Japan Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Pathological Examination Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Pathological Examination Revenue Share by Type (2021-2032) Figure 57. SAMEA Pathological Examination Revenue Share by Application (2021-2032) Figure 58. SAMEA Pathological Examination Revenue Share by Country (2021-2032) Figure 59. Brazil Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Pathological Examination Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Histopathology
  • Cytopathology
  • Immunohistochemical Pathology
  • Molecular Pathology
Applications
  • Hospital
  • Medical Laboratory
Companies covered
  • Quest Diagnostics
  • Sonic Healthcare
  • Lab Corp
  • Unilabs
  • SYNLAB International
  • BML
  • Pathologists Diagnostic
  • StageBio
  • KingMed Diagnostics Group
  • Dian Diagnostics Group
  • Adicon Clinical Laboratories Inc.
  • Huayin Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pathological Examination Market by Type
  3. 1.2.1 Global Pathological Examination Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Histopathology
  5. 1.2.3 Cytopathology
  6. 1.2.4 Immunohistochemical Pathology
  7. 1.2.5 Molecular Pathology
  8. 1.3 Pathological Examination Market by Application
  9. 1.3.1 Global Pathological Examination Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Medical Laboratory
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Pathological Examination Market Dynamics
  1. 2.1 Pathological Examination Industry Trends
  2. 2.2 Pathological Examination Industry Drivers
  3. 2.3 Pathological Examination Industry Opportunities and Challenges
  4. 2.4 Pathological Examination Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pathological Examination Market Perspective (2021-2032)
  2. 3.2 Global Pathological Examination Growth Trends by Region
  3. 3.2.1 Global Pathological Examination Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pathological Examination Market Size by Region (2021-2026)
  5. 3.2.3 Global Pathological Examination Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pathological Examination Revenue by Players
  2. 4.1.1 Global Pathological Examination Revenue by Players (2021-2026)
  3. 4.1.2 Global Pathological Examination Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pathological Examination Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pathological Examination Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pathological Examination Key Players Headquarters & Area Served
  7. 4.4 Global Pathological Examination Players, Product Type & Application
  8. 4.5 Global Pathological Examination Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pathological Examination Market CR5 and HHI
  11. 4.6.3 2025 Pathological Examination Tier 1, Tier 2, and Tier 3
5 Pathological Examination Market Size by Type
  1. 5.1 Global Pathological Examination Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pathological Examination Revenue by Type (2021-2032)
  3. 5.3 Global Pathological Examination Revenue Market Share by Type (2021-2032)
6 Pathological Examination Market Size by Application
  1. 6.1 Global Pathological Examination Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pathological Examination Revenue by Application (2021-2032)
  3. 6.3 Global Pathological Examination Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Quest Diagnostics
  2. 7.1.1 Quest Diagnostics Company Information
  3. 7.1.2 Quest Diagnostics Business Overview
  4. 7.1.3 Quest Diagnostics Pathological Examination Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Quest Diagnostics Pathological Examination Product Portfolio
  6. 7.1.5 Quest Diagnostics Recent Developments
  7. 7.2 Sonic Healthcare
  8. 7.2.1 Sonic Healthcare Company Information
  9. 7.2.2 Sonic Healthcare Business Overview
  10. 7.2.3 Sonic Healthcare Pathological Examination Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Sonic Healthcare Pathological Examination Product Portfolio
  12. 7.2.5 Sonic Healthcare Recent Developments
  13. 7.3 Lab Corp
  14. 7.3.1 Lab Corp Company Information
  15. 7.3.2 Lab Corp Business Overview
  16. 7.3.3 Lab Corp Pathological Examination Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Lab Corp Pathological Examination Product Portfolio
  18. 7.3.5 Lab Corp Recent Developments
  19. 7.4 Unilabs
  20. 7.4.1 Unilabs Company Information
  21. 7.4.2 Unilabs Business Overview
  22. 7.4.3 Unilabs Pathological Examination Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Unilabs Pathological Examination Product Portfolio
  24. 7.4.5 Unilabs Recent Developments
  25. 7.5 SYNLAB International
  26. 7.5.1 SYNLAB International Company Information
  27. 7.5.2 SYNLAB International Business Overview
  28. 7.5.3 SYNLAB International Pathological Examination Revenue and Gross Margin (2021-2026)
  29. 7.5.4 SYNLAB International Pathological Examination Product Portfolio
  30. 7.5.5 SYNLAB International Recent Developments
  31. 7.6 BML
  32. 7.6.1 BML Company Information
  33. 7.6.2 BML Business Overview
  34. 7.6.3 BML Pathological Examination Revenue and Gross Margin (2021-2026)
  35. 7.6.4 BML Pathological Examination Product Portfolio
  36. 7.6.5 BML Recent Developments
  37. 7.7 Pathologists Diagnostic
  38. 7.7.1 Pathologists Diagnostic Company Information
  39. 7.7.2 Pathologists Diagnostic Business Overview
  40. 7.7.3 Pathologists Diagnostic Pathological Examination Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Pathologists Diagnostic Pathological Examination Product Portfolio
  42. 7.7.5 Pathologists Diagnostic Recent Developments
  43. 7.8 StageBio
  44. 7.8.1 StageBio Company Information
  45. 7.8.2 StageBio Business Overview
  46. 7.8.3 StageBio Pathological Examination Revenue and Gross Margin (2021-2026)
  47. 7.8.4 StageBio Pathological Examination Product Portfolio
  48. 7.8.5 StageBio Recent Developments
  49. 7.9 KingMed Diagnostics Group
  50. 7.9.1 KingMed Diagnostics Group Company Information
  51. 7.9.2 KingMed Diagnostics Group Business Overview
  52. 7.9.3 KingMed Diagnostics Group Pathological Examination Revenue and Gross Margin (2021-2026)
  53. 7.9.4 KingMed Diagnostics Group Pathological Examination Product Portfolio
  54. 7.9.5 KingMed Diagnostics Group Recent Developments
  55. 7.10 Dian Diagnostics Group
  56. 7.10.1 Dian Diagnostics Group Company Information
  57. 7.10.2 Dian Diagnostics Group Business Overview
  58. 7.10.3 Dian Diagnostics Group Pathological Examination Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Dian Diagnostics Group Pathological Examination Product Portfolio
  60. 7.10.5 Dian Diagnostics Group Recent Developments
  61. 7.11 Adicon Clinical Laboratories Inc.
  62. 7.11.1 Adicon Clinical Laboratories Inc. Company Information
  63. 7.11.2 Adicon Clinical Laboratories Inc. Business Overview
  64. 7.11.3 Adicon Clinical Laboratories Inc. Pathological Examination Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Adicon Clinical Laboratories Inc. Pathological Examination Product Portfolio
  66. 7.11.5 Adicon Clinical Laboratories Inc. Recent Developments
  67. 7.12 Huayin Health
  68. 7.12.1 Huayin Health Company Information
  69. 7.12.2 Huayin Health Business Overview
  70. 7.12.3 Huayin Health Pathological Examination Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Huayin Health Pathological Examination Product Portfolio
  72. 7.12.5 Huayin Health Recent Developments
8 North America
  1. 8.1 North America Pathological Examination Revenue (2021-2032)
  2. 8.2 North America Pathological Examination Revenue by Type (2021-2032)
  3. 8.2.1 North America Pathological Examination Revenue by Type (2021-2026)
  4. 8.2.2 North America Pathological Examination Revenue by Type (2027-2032)
  5. 8.3 North America Pathological Examination Revenue Share by Type (2021-2032)
  6. 8.4 North America Pathological Examination Revenue by Application (2021-2032)
  7. 8.4.1 North America Pathological Examination Revenue by Application (2021-2026)
  8. 8.4.2 North America Pathological Examination Revenue by Application (2027-2032)
  9. 8.5 North America Pathological Examination Revenue Share by Application (2021-2032)
  10. 8.6 North America Pathological Examination Revenue by Country
  11. 8.6.1 North America Pathological Examination Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pathological Examination Revenue by Country (2021-2026)
  13. 8.6.3 North America Pathological Examination Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Pathological Examination Revenue (2021-2032)
  2. 9.2 Europe Pathological Examination Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pathological Examination Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pathological Examination Revenue by Type (2027-2032)
  5. 9.3 Europe Pathological Examination Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pathological Examination Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pathological Examination Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pathological Examination Revenue by Application (2027-2032)
  9. 9.5 Europe Pathological Examination Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pathological Examination Revenue by Country
  11. 9.6.1 Europe Pathological Examination Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pathological Examination Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pathological Examination Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Pathological Examination Revenue (2021-2032)
  2. 10.2 China Pathological Examination Revenue by Type (2021-2032)
  3. 10.2.1 China Pathological Examination Revenue by Type (2021-2026)
  4. 10.2.2 China Pathological Examination Revenue by Type (2027-2032)
  5. 10.3 China Pathological Examination Revenue Share by Type (2021-2032)
  6. 10.4 China Pathological Examination Revenue by Application (2021-2032)
  7. 10.4.1 China Pathological Examination Revenue by Application (2021-2026)
  8. 10.4.2 China Pathological Examination Revenue by Application (2027-2032)
  9. 10.5 China Pathological Examination Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pathological Examination Revenue (2021-2032)
  2. 11.2 Asia Pathological Examination Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pathological Examination Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pathological Examination Revenue by Type (2027-2032)
  5. 11.3 Asia Pathological Examination Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pathological Examination Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pathological Examination Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pathological Examination Revenue by Application (2027-2032)
  9. 11.5 Asia Pathological Examination Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pathological Examination Revenue by Country
  11. 11.6.1 Asia Pathological Examination Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pathological Examination Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pathological Examination Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pathological Examination Revenue (2021-2032)
  2. 12.2 SAMEA Pathological Examination Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pathological Examination Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pathological Examination Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pathological Examination Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pathological Examination Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pathological Examination Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pathological Examination Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pathological Examination Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pathological Examination Revenue by Country
  11. 12.6.1 SAMEA Pathological Examination Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pathological Examination Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pathological Examination Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst